AI assistant
Sending…
DAVITA INC. — Director's Dealing 2014
Dec 22, 2014
30643_dirs_2014-12-22_22af63c2-a669-4167-9944-6c5f99710f64.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-12-19
Reporting Person: Mildenberger Laura (Chief People Ofcr, Kidney Care)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-12-19 | Common Stock | M | 2500 | $31.70 | Acquired | 9234 | Direct |
| 2014-12-19 | Common Stock | F | 1054 | $75.20 | Disposed | 8180 | Direct |
| 2014-12-19 | Common Stock | S | 1446 | $75.50 | Disposed | 6734 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-12-19 | Stock Appreciation Rights | $31.70 | M | 2500 | Disposed | 2015-03-31 | Common Stock (2500) | Direct |
Footnotes
F1: Stock Appreciation Rights, granted on 3/31/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.
More from DAVITA INC.
Interim / Quarterly Report
2026
May 5
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Annual Report
2026
Feb 11
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 10
Earnings Release
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2025
Dec 5
Capital/Financing Update
2025
Nov 25